- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Interventional, Single centre
- Objective: To assess the safety and efficacy of plitidepsin as a potential treatment for long COVID
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 3 months
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Plitidepsin
- Antineoplastic agent
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to